Related Experiment Video
Updated: Oct 26, 2025

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Changes in miR 21 and 23b expression in postnatal hypertrophic heart derived from gestational diabetes precede
Clara Ortega -Camarillo1, Guadalupe Diaz-Rosas, Alejandro Avalos-Rodri Guez
1Medical Research Unit in Biochemistry, Specialties Hospital, National Medical Center SXXI, Instituto Mexicano del Seguro Social, CDMX, Mexico.
Insights
Gestational diabetes in rats causes fetal heart hypertrophy that resolves postnatally, but leads to ventricular remodeling and extracellular matrix changes, resembling dilated cardiomyopathy.
Area of Science:
- Cardiovascular Research
- Developmental Biology
- Endocrinology
Background:
- Gestational diabetes mellitus (GDM) is linked to fetal congenital heart defects, specifically hypertrophic cardiomyopathy (HCM).
- Understanding the postnatal progression of cardiac changes in offspring exposed to GDM is crucial for identifying long-term risks.
Purpose of the Study:
- To investigate the effects and underlying mechanisms of postnatal cardiac remodeling in rat pups born to mothers with streptozotocin-induced gestational diabetes (GD).
- To analyze the temporal changes in cardiac structure, gene expression, and extracellular matrix remodeling.
Main Methods:
- Histological analysis and collagen expression evaluation in rat pup hearts at various postnatal ages (newborn to 35 days).
- Assessment of matrix metalloproteinase-9 (MMP-9) activity using in-gel gelatin zymography.
- Quantification of adrenergic receptors (α2AR, β3AR), myosins (Myc6, Myc7), Bcl-2, and Bax mRNA via qRT-PCR.
Main Results:
- Fetal left ventricular hypertrophy persisted until postnatal day 8 but subsequently reversed, with ventricular wall thinning observed, resembling dilated cardiomyopathy (DCM).
- Ventricular remodeling correlated with altered expression of β3 adrenergic receptors and specific microRNAs (miR-21, miR-23b).
- Increased interstitial space, altered collagen types (Col2, Col3), elevated MMP-9, and Cx43 expression indicated active extracellular remodeling.
Conclusions:
- Postnatal cardiac changes in offspring of diabetic mothers involve a transition from initial hypertrophy to wall thinning and extracellular matrix remodeling.
- These adaptations suggest a complex interplay of molecular signaling pathways, including adrenergic receptors and microRNAs, contributing to altered cardiac structure and function.
- The findings highlight the potential for long-term cardiovascular consequences in offspring exposed to GDM, necessitating further investigation into preventative and therapeutic strategies.
Abstract:
Gestational diabetes mellitus (GDM) increases the risk of fetal congenital ventricular hypertrophic cardiomyopathy (HCM). We explored the effects and mechanisms of the postnatal progression of fetal hypertrophic failure in rat pups with STZ-induced Gestational Diabetes (GD). The hearts of rat pups (newborn [NB], 8, 15, 25 and 35 days postnatal) were obtained. Histological characteristics and expression of collagen were evaluated. In-gel-gelatin zymography for MMP-9 activation was performed. Adrenergic receptors (α2AR and β3AR), myosins (Myc6 and Myc7), Bcl-2 and Bax mRNA expression were quantified by qRT-PCR. Fetal hypertrophy of the left ventricular lateral wall (LVLW) in rat pups with DG persists until day 8, although this process appears to be reversed during the postnatal stage. The temporal continuity of the study demonstrated a thinning of the ventricular wall, similar to dilated cardiomyopathy (DCM). This ventricular remodeling process is associated with the expression of β3 adrenergic receptors and miR-21, -23b. The Bax/Bcl2 ratio was significantly reduced only at early ages. In addition, the increase in interstitial space in all ages, as well as the predominance of early ages expression of Col2 and increased expression of Col3, MMP-9 and Cx43 in late ages, is the result of an active extracellular remodeling in the hearts of rat pups with GD.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure II: Pathophysiology

